{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:35:23Z","timestamp":1783571723224,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-024-00933-8","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T09:23:45Z","timestamp":1730971425000},"page":"271-279","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Managing malignant hypertension with renal TMA: a case for caution in blood-pressure reduction"],"prefix":"10.1007","volume":"14","author":[{"given":"Narumichi","family":"Iwamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5416-3919","authenticated-orcid":false,"given":"Yuta","family":"Matsukuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Katafuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"933_CR1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/ajh\/hpx008","volume":"30","author":"A Shantsila","year":"2017","unstructured":"Shantsila A, Lip GYH. Malignant hypertension revisited\u2014does this still exist? Am J Hypertens. 2017;30:543\u20139. https:\/\/doi.org\/10.1093\/ajh\/hpx008.","journal-title":"Am J Hypertens"},{"key":"933_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/jch.12243","volume":"16","author":"F Amraoui","year":"2014","unstructured":"Amraoui F, Van Der Hoeven NV, Van Valkengoed IGM, et al. Mortality and cardiovascular risk in patients with a history of malignant hypertension: a case-control study. J Clin Hypertens. 2014;16:122\u20136. https:\/\/doi.org\/10.1111\/jch.12243.","journal-title":"J Clin Hypertens"},{"key":"933_CR3","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/ckj\/sfu116","volume":"7","author":"C Nzerue","year":"2014","unstructured":"Nzerue C, Oluwole K, Adejorin D, et al. Malignant hypertension with thrombotic microangiopathy and persistent acute kidney injury (AKI). Clin Kidney J. 2014;7:586\u20139. https:\/\/doi.org\/10.1093\/ckj\/sfu116.","journal-title":"Clin Kidney J"},{"key":"933_CR4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1053\/j.ajkd.2022.10.014","volume":"81","author":"DS Genest","year":"2023","unstructured":"Genest DS, Patriquin CJ, Licht C, et al. Renal thrombotic microangiopathy: a review. Am J Kidney Dis. 2023;81:591\u2013605. https:\/\/doi.org\/10.1053\/j.ajkd.2022.10.014.","journal-title":"Am J Kidney Dis"},{"key":"933_CR5","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension Global Hypertension practice guidelines. Hypertens. 2020;75:1334\u201357. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.15026.","journal-title":"Hypertens"},{"key":"933_CR6","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1161\/HYPERTENSIONAHA.107.103127","volume":"51","author":"BH Van den Born","year":"2008","unstructured":"Van den Born BH, Van der Hoeven NV, Groot R, et al. Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension. Hypertens. 2008;51:862\u20136. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.107.103127.","journal-title":"Hypertens"},{"key":"933_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1291\/hypres.28.89","volume":"28","author":"Y Shibagaki","year":"2005","unstructured":"Shibagaki Y, Fujita T. Thrombotic microangiopathy in malignant hypertension and haemolytic uremic syndrome (HUS)\/thrombotic thrombocytopenic. Hypertens Res. 2005;28:89\u201395. https:\/\/doi.org\/10.1291\/hypres.28.89.","journal-title":"Hypertens Res"},{"key":"933_CR8","doi-asserted-by":"publisher","first-page":"bcr2017220457","DOI":"10.1136\/bcr-2017-220457","volume":"2017","author":"G Thind","year":"2017","unstructured":"Thind G, Kailasam K. Malignant hypertension as a rare cause of thrombotic microangiopathy. BMJ Case Rep. 2017;2017:bcr2017220457. https:\/\/doi.org\/10.1136\/bcr-2017-220457.","journal-title":"BMJ Case Rep"},{"key":"933_CR9","first-page":"504","volume":"29","author":"I Aijazi","year":"2017","unstructured":"Aijazi I, Shama FA, Raman LG, et al. Malignant hypertension complicated by renal thrombotic micro angiopathy: role of ADAM 13 mutational analyses. J Ayub Med Coll Abbottabad. 2017;29:504\u20137. http:\/\/www.jamc.ayubmed.edu.pk.","journal-title":"J Ayub Med Coll Abbottabad"},{"issue":"bcr10","key":"933_CR10","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1136\/bcr.10.2008.1116","volume":"2009","author":"X Li","year":"2008","unstructured":"Li X, Zhang W, Ren H, et al. Malignant hypertension complicated by acute renal failure. BMJ Case Rep. 2008;2009(bcr10):1116. https:\/\/doi.org\/10.1136\/bcr.10.2008.1116.","journal-title":"BMJ Case Rep"},{"key":"933_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4009\/jsdt.40.95","volume":"40","author":"H Uchiyama","year":"2007","unstructured":"Uchiyama H, Taniguchi K, Kato H, et al. A young case of malignant hypertension complicated by thrombotic microangiopathy. J Jpn Soc Dial Ther. 2007;40:95\u2013100. https:\/\/doi.org\/10.4009\/jsdt.40.95.","journal-title":"J Jpn Soc Dial Ther"},{"key":"933_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1291\/hypres.28.89","volume":"28","author":"Y Shibagaki","year":"2005","unstructured":"Shibagaki Y, Fujita T. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)\/thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other? Hypertens Res. 2005;28:89\u201395. https:\/\/doi.org\/10.1291\/hypres.28.89.","journal-title":"Hypertens Res"},{"key":"933_CR13","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023397","volume":"11","author":"R Boulestreau","year":"2022","unstructured":"Boulestreau R, Born BH, Lip G, et al. Malignant hypertension: current perspectives and challenges. J Am Heart Assoc. 2022;11: e023397. https:\/\/doi.org\/10.1161\/JAHA.121.023397.","journal-title":"J Am Heart Assoc"},{"key":"933_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s11906-014-0436-x","volume":"16","author":"L Manning","year":"2014","unstructured":"Manning L, Robinson TG, Anderson CS. Control of blood pressure in hypertensive neurological emergencies. Curr Hypertens Rep. 2014;16:436. https:\/\/doi.org\/10.1007\/s11906-014-0436-x.","journal-title":"Curr Hypertens Rep"},{"key":"933_CR15","first-page":"85","volume":"58","author":"K Kohagura","year":"2016","unstructured":"Kohagura K, Ohya Y. Benign nephrosclerosis and malignant nephrosclerosis. Jpn J Nephrol. 2016;58:85\u201391. https:\/\/jsn.or.jp\/journal\/document\/58_2\/085-091.pdf.","journal-title":"Jpn J Nephrol"},{"key":"933_CR16","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000080","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive summary: a report of the American College of Cardiology\/American heart association Task force on clinical practice guidelines. Hypertension. 2018;71:1269\u2013324. https:\/\/doi.org\/10.1161\/HYP.0000000000000080","journal-title":"Hypertension"},{"key":"933_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/ehjcvp\/pvy032","volume":"5","author":"B-JH van den Born","year":"2019","unstructured":"van den Born B-JH, Lip GYH, Brguljan-Hitij J, et al. ESC Council on hypertension position document on the management of hypertensive emergencies. Eur Heart J Cardiovasc Pharmacother. 2019;5:37\u201346. https:\/\/doi.org\/10.1093\/ehjcvp\/pvy032","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"issue":"13","key":"933_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1471-2369-13-71","volume":"30","author":"F Amraoui","year":"2012","unstructured":"Amraoui F, Bos S, Vogt L, van den Born BJ. Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study. BMC Nephrol. 2012;30(13):71. https:\/\/doi.org\/10.1186\/1471-2369-13-71.","journal-title":"BMC Nephrol"},{"issue":"1","key":"933_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2215\/CJN.05510517","volume":"13","author":"R Magri\u00e7o","year":"2018","unstructured":"Magri\u00e7o R, Vieira MB, Dias CV, e al. BP reduction, kidney function decline, and cardiovascular events in patients without CKD. Clinical J Am Soc Nephrol. 2018;13(1):73\u201380. https:\/\/doi.org\/10.2215\/CJN.05510517","journal-title":"Clinical J Am Soc Nephrol"},{"issue":"6","key":"933_CR20","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1097\/HJH.0000000000000902","volume":"34","author":"M Satoh","year":"2016","unstructured":"Satoh M, Haga T, Hosaka M, et al. The velocity of antihypertensive effects of seven angiotensin II receptor blockers determined by home blood pressure measurements. J Hypertens. 2016;34(6):1218\u201323. https:\/\/doi.org\/10.1097\/HJH.0000000000000902.","journal-title":"J Hypertens"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-024-00933-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-024-00933-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-024-00933-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T03:24:18Z","timestamp":1743650658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-024-00933-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["933"],"URL":"https:\/\/doi.org\/10.1007\/s13730-024-00933-8","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists. The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}